THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER

NCT ID: NCT07237503

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-15

Study Completion Date

2026-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: This study was carried out to investigate fatigue and exercise barriers of calisthenic exercises in patients with lung cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer (NSCLC) Physiotherapy Fatigue in Cancer Survivors Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

During the 8-week period, both groups completed exercise training three times a week at low to moderate intensity (50-60% of maximal heart rate). In the first week, patients in both groups were allowed to exercise as much as they could tolerate, with more frequent rest intervals provided. Starting from the third week, as patients' tolerance improved, rest intervals were reduced and the number of repetitions was adjusted to 10. By the second month, for patients who were able to tolerate more, the number of repetitions was increased to 12, and in the following week, exercises were planned as 2 sets for suitable patients.

In the Physiotherapist-Led Exercise group, the exercise sessions were conducted under the supervision of a physiotherapist, and patients' respiratory rate, fatigue severity, blood pressure, and pain were regularly monitored.

In the Home Exercise Training group, the same exercises were demonstrated practically during the first session, and patients were instructed to re
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Physiotherapist-Led Exercise

Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.

Group Type EXPERIMENTAL

Exercise

Intervention Type BEHAVIORAL

Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.

Home Exercise Group

. Patients in Group 2 were given an exercise booklet and followed up with weekly controls.

Group Type ACTIVE_COMPARATOR

Home based exercise

Intervention Type BEHAVIORAL

Patients in Group 2 were given an exercise booklet and followed up with weekly controls.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise

Patients in Group 1 were exercised 3 days a week for 8 weeks at 50-60% of maximal heart rate for 40 min, accompanied by a physiotherapist.

Intervention Type BEHAVIORAL

Home based exercise

Patients in Group 2 were given an exercise booklet and followed up with weekly controls.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To be between the ages of 18-65
* Patients with lung cancer who continue to receive chemotherapy, radiotherapy or immunotherapy (smart drugs)
* Patients reporting fatigue of 3 or more on the Modified Borg Scale

Exclusion Criteria

* Uncontrolled hypertension, diabetes mellitus, heart failure and atrial fibrillation
* Any acute infection at the time of assessment
* Those with orthopaedic, neurological, psychological, etc. problems that may limit the assessments
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hasan Kalyoncu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kardelen HATIMOĞULLARI

specialist physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hasan Kalyoncu Üniversitesi

Gaziantep, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025/051

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.